Compare SRFM & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRFM | COYA |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.4M | 97.8M |
| IPO Year | 2023 | 2022 |
| Metric | SRFM | COYA |
|---|---|---|
| Price | $1.16 | $4.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $3.25 | ★ $15.80 |
| AVG Volume (30 Days) | ★ 3.6M | 161.5K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.69 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $106,557,000.00 | $7,945,753.00 |
| Revenue This Year | $25.90 | N/A |
| Revenue Next Year | $20.72 | $763.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $1.01 | $3.71 |
| 52 Week High | $9.35 | $7.75 |
| Indicator | SRFM | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 46.06 | 56.35 |
| Support Level | $1.06 | $4.50 |
| Resistance Level | $1.36 | $5.18 |
| Average True Range (ATR) | 0.09 | 0.32 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 33.33 | 49.99 |
Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.